首頁 > 市場調查報告書 > 製藥

醫藥品法規環境

市場調查報告書

商品編碼

1547885

全球藥物警戒與藥物安全軟體市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Pharmacovigilance and Drug Safety Software Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球藥物警戒和藥物安全軟體市場需求預計將從 2023 年的 2.0157 億美元達到 2032 年的近 3.7939 億美元，2024-2032 年研究期間複合年成長率為 7.28%。

藥物警戒和藥物安全軟體是一種降低產品安全風險、實現合規性並提高藥物警戒流程效率的應用程式。它可以確定戒斷的原因，並有助於抑制未來不必要的事件。軟體報告並管理安全和監管，持續追蹤向政府和客戶提供的狀態報告，允許存取記錄和醫學進步專業知識。該軟體得到了監管機構、製藥公司和醫療專業人員的批准。

市場動態

自動化和數位化是每個領域的日益成長的趨勢，包括臨床研究。對新療法和藥物的不斷成長的研究正在促進市場的成長。危及生命的傳染性疾病對死亡率和發病率有巨大影響，並給受影響國家帶來嚴重的經濟困難。目前，現有藥物不足以治療大多數此類疾病，迫切需要新的治療方法。從研究開始到結束，藥物警戒軟體在臨床研究中發揮著至關重要的作用。該軟體透過將資訊整合到熟悉的位置來幫助減輕管理負擔和工作量，透過促進所有研究之間的合作來支持試驗輪次。該軟體的結合極大地提高了研究或研究資料的維護、規劃、執行、管理和報告的速度和效率。藥物警戒和藥物安全軟體是臨床研究領域收集試驗資料以追蹤研究表現、時間表、監測等的重要工具。由於具有巨大的優勢，預計將有越來越多的臨床研究使用該軟體來獲取收益，最終將導致市場的健康成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球藥物警戒和藥物安全軟體市場的每個細分市場進行包容性評估。藥物警戒和藥物安全軟體產業的成長和趨勢為本研究提供了整體方法。

市場區隔

藥物警戒和藥物安全軟體市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按功能分類

案例資料收集和管理
不良事件報告和分析
訊號偵測及其他安全風險評估

按交付方式

內部部署
一經請求

按最終用途

醫療保健公司（製藥和生物技術公司）
外包時的 CRO/BPO 或光伏服務供應商。
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲藥物警戒和藥物安全軟體市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。藥物警戒和藥物安全軟體市場的主要參與者包括 IQVIA、埃森哲、Cognizant、Laboratory Corporation Of America Holdings、IBM、ArisGlobal、ICON Plc.、Capgemini、Oracle、Parexel International Corporation。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：藥物警戒與藥品安全軟體公司的競爭格局

藥物警戒和藥物安全軟體市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
IQVIA

公司概況
公司收入
產品
最新動態

Accenture

公司概況
公司收入
產品
最新動態

Cognizant

公司概況
公司收入
產品
最新動態

Laboratory Corporation Of America Holdings

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

ArisGlobal

公司概況
公司收入
產品
最新動態

ICON Plc.

公司概況
公司收入
產品
最新動態

Capgemini

公司概況
公司收入
產品
最新動態

Oracle

公司概況
公司收入
產品
最新動態

Parexel International Corporation

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11212598

The global demand for Pharmacovigilance and Drug Safety Software Market is presumed to reach the market size of nearly USD 379.39 Million by 2032 from USD 201.57 Million in 2023 with a CAGR of 7.28% under the study period 2024-2032.

Pharmacovigilance and drug safety software is an application that reduces product safety risk, achieves compliance, and improves the efficiency of pharmacovigilance processes. It identifies the cause of withdrawal and helps to inhibit unnecessary future events. Software reports and manages safety and regulation, consistently track status reports to governments and clients, enable access to records, and medicine advancement expertise. The software is approved by regulating agencies, pharmaceutical companies, and medical professionals.

MARKET DYNAMICS

Automation and digitalization is an increasing trend in every sector, including clinical research. Growing research on new therapies and drugs is augmenting the growth of the market. Infectious life-threatening diseases have a massive effect in terms of mortality and morbidity and oblige substantial economic trouble on affected countries. Currently, available drugs are insufficient for the majority of these diseases, and there is an urgent need for new treatments. From a research start to close out, pharmacovigilance software plays a crucial role in clinical research. This software help reduce the administrative burdens and workloads by consolidating information in a familiar location, supports the trial round by facilitating the cooperation between all the researches. Incorporation of this software dramatically enhances the speed and efficiency in maintaining, planning, performing, managing, and reporting of the research or study data. Pharmacovigilance and Drug Safety Softwares are great tools in the clinical research domain to collect trial data to track study performance, schedule, monitor, and many more. Due to a massive bundle of advantages, it is predicted that more and more clinical research will use this software to grab the benefits that will eventually result in the healthy growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Pharmacovigilance and Drug Safety Software. The growth and trends of Pharmacovigilance and Drug Safety Software industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Pharmacovigilance and Drug Safety Software market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Functionality

Case Data Collection and Management
Adverse Event Reporting and Analysis
Signal Detection and Other Safety Risk Assessment

By Delivery Mode

On Premise
On Demand

By End Use

Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
CROs/BPOs or PV Service Providers When Outsourced.
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pharmacovigilance and Drug Safety Software market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmacovigilance and Drug Safety Software market include IQVIA, Accenture, Cognizant, Laboratory Corporation Of America Holdings, IBM, ArisGlobal, ICON Plc., Capgemini, Oracle, Parexel International Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Functionality
- 3.7.2 Market Attractiveness Analysis By Delivery Mode
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ANALYSIS BY FUNCTIONALITY

5.1. Overview By Functionality
5.2. Historical and Forecast Data
5.3. Analysis By Functionality
5.4. Case Data Collection and Management Historic and Forecast Sales By Regions
5.5. Adverse Event Reporting and Analysis Historic and Forecast Sales By Regions
5.6. Signal Detection and Other Safety Risk Assessment Historic and Forecast Sales By Regions

6. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ANALYSIS BY DELIVERY MODE

6.1. Overview By Delivery Mode
6.2. Historical and Forecast Data
6.3. Analysis By Delivery Mode
6.4. On Premise Historic and Forecast Sales By Regions
6.5. On Demand Historic and Forecast Sales By Regions

7. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ANALYSIS BY END USE

7.1. Overview By End Use
7.2. Historical and Forecast Data
7.3. Analysis By End Use
7.4. Healthcare Companies (Pharmaceuticals & Biotechnology Companies) Historic and Forecast Sales By Regions
7.5. CROs/BPOs or PV Service Providers When Outsourced. Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE COMPANIES

9.1. Pharmacovigilance and Drug Safety Software Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. IQVIA
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Accenture
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Cognizant
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Laboratory Corporation Of America Holdings
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. IBM
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. ArisGlobal
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. ICON Plc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Capgemini
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Oracle
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Parexel International Corporation
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Functionality (USD MN)
Case Data Collection and Management Market Sales By Geography (USD MN)
Adverse Event Reporting and Analysis Market Sales By Geography (USD MN)
Signal Detection and Other Safety Risk Assessment Market Sales By Geography (USD MN)
Analysis By Delivery Mode (USD MN)
On Premise Market Sales By Geography (USD MN)
On Demand Market Sales By Geography (USD MN)
Analysis By End Use (USD MN)
Healthcare Companies (Pharmaceuticals & Biotechnology Companies) Market Sales By Geography (USD MN)
CROs/BPOs or PV Service Providers When Outsourced. Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Pharmacovigilance and Drug Safety Software Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Pharmacovigilance and Drug Safety Software Report
Market Research Process
Market Research Methodology
Global Pharmacovigilance and Drug Safety Software Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Functionality
Market Attractiveness Analysis By Delivery Mode
Market Attractiveness Analysis By End Use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Functionality (USD MN)
Case Data Collection and Management Market Sales By Geography (USD MN)
Adverse Event Reporting and Analysis Market Sales By Geography (USD MN)
Signal Detection and Other Safety Risk Assessment Market Sales By Geography (USD MN)
Global Market Analysis By Delivery Mode (USD MN)
On Premise Market Sales By Geography (USD MN)
On Demand Market Sales By Geography (USD MN)
Global Market Analysis By End Use (USD MN)
Healthcare Companies (Pharmaceuticals & Biotechnology Companies) Market Sales By Geography (USD MN)
CROs/BPOs or PV Service Providers When Outsourced. Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis